Cirqle Biomedical is a mucus engineering company developing OUI®, a first-in-class non-hormonal contraceptive. OUI® provides side-effect free contraception by topically reinforcing the natural barrier properties of cervical mucus and thereby preventing sperm cells from reaching the egg.
Cirqle Biomedical is a spin-out from KTH Royal Institute of Technology (SE) established in 2019, backed by Rhia Ventures (US) and BioInnovation Institute (DK).